The global polycythemia vera therapeutics market is estimated to be valued at US$ 1,115.9 million in 2021 and is expected to exhibit a CAGR of 4.5% over the forecast period (2021-2028).
The increasing incidence of polycythemia vera is expected to drive the growth of the global polycythemia vera therapeutics market over the forecast period.
Figure 1. Global Polycythemia Vera Therapeutics Market Share (%), By Region, 2021
The increasing research and development activities for the development of novel therapeutics for the treatment of polycythemia vera is expected to drive the market growth over the forecast period.
Figure 2. Global Polycythemia Vera Therapeutics Market Value (US$ Mn), By Drug Class, 2021
Polycythemia Vera Therapeutics Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients